DZK Recommendations for Tuberculosis, BCG and COVID-19 in Germany (Official Abbreviation of Coronavirus Disease 2019 Caused by the New Coronavirus SARS-CoV-2)

被引：4
|
作者：
Otto-Knapp, R. [1 ]
Haecker, B. [1 ]
Breuer, C. [1 ,2 ]
Diel, R. [1 ,3 ]
Kaufmann, S. H. E. [4 ]
Korr, G. [5 ]
Pfeiffer, M. [1 ,6 ,7 ]
Schaberg, T. [1 ]
Schoenfeld, N. [1 ,8 ]
Witte, P. [1 ,9 ]
Bauer, T. [1 ,7 ,8 ]
机构：
[1] Deutsch Zentralkomitee Bekampfung TB eV DZK, Walterhoferstr 11,Haus Q, D-14165 Berlin, Germany
[2] Gesundheitsamt Dresden, Dresden, Germany
[3] Airway Dis Ctr North ARCN, LungenClin Grosshansdorf, Grosshansdorf, Germany
[4] Max Planck Inst Infekt Biol, Berlin, Germany
[5] Bundesminist Gesundheit, Berlin, Germany
[6] Univ Klinikum Regensburg, Klin Donaustauf, Regensburg, Germany
[7] Deutsch Gesell Pneumol eV DGP, Leipzig, Germany
[8] Lungenklin Heckeshorn, Helios Klinikum Emil von Behring, Berlin, Germany
[9] Univ Klinikum Johannes Wesling Minden, Inst Krankenhaushyg Muhlenkreiskliniken, Minden, Germany
来源：
PNEUMOLOGIE | 2020年 / 74卷 / 07期
关键词：
VACCINE; MENINGITIS; TRIALS;
D O I：
10.1055/a-1199-6721
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：412 / 416
页数：5
相关论文
共 50 条
  • [31] New onset or relapsing neuromyelitis optica temporally associated with SARS-CoV-2 infection and COVID-19 vaccination: a systematic review
    Harel, Tamar
    Gorman, Emily F.
    Wallin, Mitchell T.
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [32] Multiple Sclerosis Patients and Disease Modifying Therapies: Impact on Immune Responses against COVID-19 and SARS-CoV-2 Vaccination
    Golshani, Maryam
    Hrdy, Jiri
    VACCINES, 2022, 10 (02)
  • [33] Association between COVID-19 Primary Vaccination and Severe Disease Caused by SARS-CoV-2 Delta Variant among Hospitalized Patients: A Belgian Retrospective Cohort Study
    Robalo, Queeny
    De Mot, Laurane
    Vandromme, Mathil
    Van Goethem, Nina
    Gabrio, Andrea
    Chung, Pui Yan Jenny
    Meurisse, Marjan
    Catteau, Lucy
    Thijs, Carel
    Blot, Koen
    VACCINES, 2023, 11 (01)
  • [34] Utilizing non-human primate models to combat recent COVID-19/SARS-CoV-2 and viral infectious disease outbreaks
    Kwon, Taeho
    JOURNAL OF MEDICAL PRIMATOLOGY, 2024, 53 (01)
  • [35] Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer
    Mueller, Thomas
    CLINICA CHIMICA ACTA, 2021, 518 : 9 - 16
  • [36] Operational strategies to deal with the COVID-19 emergency: recommendations from the Italian national society SIAGASCOT following the introduction of vaccines against the SARS-CoV-2 infection
    Compagnoni R.
    Cucchi D.
    Klumpp R.
    Ronga M.
    Berruto M.
    Di Giacomo G.
    Randelli P.S.
    MUSCULOSKELETAL SURGERY, 2023, 107 (4) : 471 - 479
  • [37] Impact of disease-modifying treatments on humoral response after COVID-19 vaccination: A mirror of the response after SARS-CoV-2 infection
    Bigaut, K.
    Kremer, L.
    Fleury, M.
    Lanotte, L.
    Collongues, N.
    de Seze, J.
    REVUE NEUROLOGIQUE, 2021, 177 (10) : 1237 - 1240
  • [38] The effectiveness of BNT162b2 mRNA vaccine against COVID-19 caused by Delta variant of SARS-CoV-2: a systematic review and meta-analysis
    Kow, Chia Siang Chia
    Ramachandram, Dinesh Sangarran
    Hasan, Syed Shahzad
    INFLAMMOPHARMACOLOGY, 2022, 30 (01) : 149 - 157
  • [39] SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection
    Hoyois, A.
    Gulkilik, C.
    Mekkaoui, L.
    Dahma, H.
    Wambacq, V.
    Minsar, C.
    Rosewick, N.
    Liefferinckx, C.
    Amininejad, L.
    Van Gossum, A.
    Cremer, A.
    Vandenberg, O.
    Franchimont, D.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2024, 87 (02) : 263 - 273
  • [40] The effectiveness of BNT162b2 mRNA vaccine against COVID-19 caused by Delta variant of SARS-CoV-2: a systematic review and meta-analysis
    Chia Siang Chia Kow
    Dinesh Sangarran Ramachandram
    Syed Shahzad Hasan
    Inflammopharmacology, 2022, 30 : 149 - 157
12345